Combining Antigen-based therapy with GABA treatment synergistically prolongs survival of transplanted ß-cells in diabetic NOD mice

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Tian, Jide ^a   Dang, Hoa ^a   Kaufman, Daniel L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ALUMINUM POTASSIUM SULFATE; DRINKING WATER; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BASED THERAPY; ARTICLE; CELL SURVIVAL; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LOW DRUG DOSE; MONOTHERAPY; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; RECURRENT DISEASE; ANIMAL; FEMALE; HUMAN;

ANIMALIA; MUS;

ANIMALS; DIABETES MELLITUS, TYPE 1; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; HUMANS; HYPERGLYCEMIA; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED NOD;

EID: 80053085802     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025337     Document Type: Article

References (27)

1. Matthews JB, Staeva TP, Bernstein PL, Peakman M, von Herrath M, (2010) Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group. Clin Exp Immunol 160: 176-184.
2. Tian J, Chau C, Hales TG, Kaufman DL, (1999) GABA(A) receptors mediate inhibition of T cell responses. J Neuroimmunol 96: 21-28.
3. Tian J, Lu Y, Zhang H, Chau CH, Dang HN, et al. (2004) Gamma-aminobutyric acid inhibits T cell autoimmunity and the development of inflammatory responses in a mouse type 1 diabetes model. J Immunol 173: 5298-5304.
4. Bhat R, Axtell R, Mitra A, Miranda M, Lock C, et al. (2010) Inhibitory role for GABA in autoimmune inflammation. Proc Natl Acad Sci U S A 107: 2580-2585.
5. Tian J, Yong J, Dang H, Kaufman DL, (2011) Oral GABA treatment downregulates inflammatory responses in a mouse model of rheumatoid arthritis. Autoimmunity 44: 465-470.
6. Tian J, Dang H, Yong J, Chui W-S, Dizon M, et al. (2011) Oral treatment with γ-aminobutyric acid improves glucose tolerance and insulin sensitivity by inhibiting inflammation in high fat diet-fed mice. PLoS ONE (in press).
7. Tian J, Kaufman DL, (2009) Antigen-based therapy for the treatment of type 1 diabetes. Diabetes 58: 1939-1946.
8. Tian J, Clare-Salzler M, Herschenfeld A, Middleton B, Newman D, et al. (1996) Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nat Med 2: 1348-1353.
9. Pop SM, Wong CP, He Q, Wang Y, Wallet MA, et al. (2007) The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice. Diabetes 56: 1395-1402.
10. Yip HC, Karulin AY, Tary-Lehmann M, Hesse MD, Radeke H, et al. (1999) Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response. J Immunol 162: 3942-3949.
11. Olcott AP, Tian J, Walker V, Dang H, Middleton B, et al. (2005) Antigen-based therapies using ignored determinants of beta cell antigens can more effectively inhibit late-stage autoimmune disease in diabetes-prone mice. J Immunol 175: 1991-1999.
12. Suarez-Pinzon WL, Rabinovitch A, (2008) Combination therapy with epidermal growth factor and gastrin delays autoimmune diabetes recurrence in nonobese diabetic mice transplanted with syngeneic islets. Transplant Proc 40: 529-532.
13. Agardh CD, Cilio CM, Lethagen A, Lynch K, Leslie RD, et al. (2005) Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes. J Diabetes Complications 19: 238-246.
14. Ludvigsson J, Faresjo M, Hjorth M, Axelsson S, Cheramy M, et al. (2008) GAD Treatment and Insulin Secretion in Recent-Onset Type 1 Diabetes. N Engl J Med 359: 1909-1920.
15. Wherrett DK, Bundy B, Becker DJ, Dimeglio LA, Gitelman SE, et al. (2011) Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial. Lancet 378: 319-327.
16. Gu XH, Kurose T, Kato S, Masuda K, Tsuda K, et al. (1993) Suppressive effect of GABA on insulin secretion from the pancreatic beta-cells in the rat. Life Sci 52: 687-694.
17. Rorsman P, Berggren PO, Bokvist K, Ericson H, Mohler H, et al. (1989) Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels. Nature 341: 233-236.
18. Braun M, Ramracheya R, Bengtsson M, Clark A, Walker JN, et al. (2010) Gamma-aminobutyric acid (GABA) is an autocrine excitatory transmitter in human pancreatic beta-cells. Diabetes 59: 1694-1701.
19. Ligon B, Yang J, Morin SB, Ruberti MF, Steer ML, (2007) Regulation of pancreatic islet cell survival and replication by gamma-aminobutyric acid. Diabetologia 50: 764-773.
20. Soltani N, Qiu H, Aleksic M, Glinka Y, Zhao F, et al. (2011) GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes. Proc Natl Acad Sci U S A 108: 11692-11697.
21. Peakman M, von Herrath M, (2010) Antigen-specific immunotherapy for type 1 diabetes: maximizing the potential. Diabetes 59: 2087-2093.
22. Lewis RS, Cahalan MD, (1995) Potassium and calcium channels in lymphocytes. Annu Rev Immunol 13: 623-653.
23. Cahalan MD, Lewis RS, (1994) Regulation of chloride channels in lymphocytes. Current Topics in Membranes 42: 103-129.
24. Otomo E, Araki G, Mori A, Kurihara M, (1981) Clinical evaluation of GABA in the treatment of cerebrovascular disorders. Multi-center double-blind study in comparison with pyrithioxine and placebo. Arzneimittelforschung 31: 1511-1523.
25. Loeb C, Benassi E, Bo GP, Cocito L, Maffini M, et al. (1987) Preliminary evaluation of the effect of GABA and phosphatidylserine in epileptic patients. Epilepsy Res 1: 209-212.
26. Tower DB, Roberts E, eds. (1960) Inhibition in the Nervous System and GABA. New York Pergamon Press pp. 562-578.
27. Alam S, Laughton DL, Walding A, Wolstenholme AJ, (2006) Human peripheral blood mononuclear cells express GABAA receptor subunits. Mol Immunol 43: 1432-1442.